United Therapeutics to repurchase remainder under $2.0 billion authorization
United Therapeutics Corporation announced an accelerated share repurchase agreement for the remainder of its $2.0 billion authorization.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.